A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques ; volume:9 ; number:2 ; day:13 ; month:9 ; year:2012 ; pages:1 ; date:9.2012
Retrovirology ; 9, Heft 2 (13.9.2012), 1, 9.2012
- Creator
-
Jensen, K.
- Contributor
-
Ranganathan, UD
Kozlowski, P.
Van Rompay, K.
Canfield, D.
Ravindran, R.
Khan, I.
Luciw, P.
Fennelly, G.
Larsen, M.
Abel, K.
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-9-S2-O4
- URN
-
urn:nbn:de:1111-2016080724463
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jensen, K.
- Ranganathan, UD
- Kozlowski, P.
- Van Rompay, K.
- Canfield, D.
- Ravindran, R.
- Khan, I.
- Luciw, P.
- Fennelly, G.
- Larsen, M.
- Abel, K.
- SpringerLink (Online service)
Other Objects (12)
Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys
Increased neutrophil apoptosis in chronically SIV-infected macaques
IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques
SiV
P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques
Loss and regain of SIV control upon CD8+ cell depletion in vivo in SIV-controller macaques is not associated with efficient SIV specific CD8+ T-cells
Live, attenuated rubella vectors expressing HIV and SIV vaccine antigens
STING agonists activate latently infected cells and enhance SIV-specific responses ex vivo in naturally SIV controlled cynomolgus macaques
No evidence for ongoing replication on ART in SIV-infected macaques
Live attenuated rubella vectors expressing SIV and HIV vaccine antigens replicate and elicit durable immune responses in rhesus macaques
Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys
Increased neutrophil apoptosis in chronically SIV-infected macaques
IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques
SiV
P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques
Loss and regain of SIV control upon CD8+ cell depletion in vivo in SIV-controller macaques is not associated with efficient SIV specific CD8+ T-cells
Live, attenuated rubella vectors expressing HIV and SIV vaccine antigens
STING agonists activate latently infected cells and enhance SIV-specific responses ex vivo in naturally SIV controlled cynomolgus macaques
No evidence for ongoing replication on ART in SIV-infected macaques
Live attenuated rubella vectors expressing SIV and HIV vaccine antigens replicate and elicit durable immune responses in rhesus macaques
Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys
Increased neutrophil apoptosis in chronically SIV-infected macaques
IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques
SiV
P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques
Loss and regain of SIV control upon CD8+ cell depletion in vivo in SIV-controller macaques is not associated with efficient SIV specific CD8+ T-cells
Live, attenuated rubella vectors expressing HIV and SIV vaccine antigens
STING agonists activate latently infected cells and enhance SIV-specific responses ex vivo in naturally SIV controlled cynomolgus macaques
No evidence for ongoing replication on ART in SIV-infected macaques